(Press-News.org) Lugano, Switzerland, 27 August 2025 – The Molecular Analysis for Precision Oncology Congress 2025 (MAP) will bring together leading experts to explore the latest advances in cancer research, with a focus on deepening the understanding of disease mechanism and enhancing strategies for prevention and interception. Key topics will include the integration of AI in diagnostics and therapy, alongside advances in immunotherapy and emerging developments in aging, cellular senescence, the microbiome, and cancer metabolism — all contributing to the evolving landscape of precision oncology.
The congress will be held onsite in Paris, France, from 15-16 September, with no virtual option available.
Programme picks
Data on T cell behavior analyse changes in the immune system during cancer development, providing insights to intercept the disease at the pre-cancer stage before it progresses to a more advanced form.
Related Content: Abstracts 178O, 22MO; educational session
Findings on the use of spatial multi-omic mapping in certain breast cancer types to investigate factors influencing ctDNA release and the transition from early-stage to invasive disease.
Related Content: Abstracts 126O, 179MO
Insights into artificial intelligence in cancer research: from developing a computer model to detect early signs of cachexia in brain cancer patients, to creating AI-powered digital twins of tumors to improve treatment and outcomes in Cancer of Unknown Primary (CUP).
Related Content: Abstracts 1MO, 2MO
Results from a trial exploring how low levels of genomic alterations are associated with exceptional and unexpected responses to targeted therapies in patients with advanced solid tumors.
Related Content: Abstract 125O
Keynote Lecture “Cancer genomics and mutational processes” by Núria López-Bigas, 16 September 2025, 14:00 – 14:30 CEST
The abstracts will be published online as a supplement to ESMO Open. The abstract titles can be viewed through the online programme.
Press accreditation
The MAP organisers welcome press representatives working for recognised press outlets interested in obtaining information and reporting on cancer issues, upon presentation of a letter of assignment and a valid press card. Press representatives are required to observe and abide by the ESMO Policy on Press Activities and the embargo schedule for MAP 2025. To apply for press accreditation, please fill out the form available here. Please be kindly informed that onsite press accreditations will not be available.
Third Parties Media registration
Third Parties Media representatives and Filming Crews not eligible as press, must abide by the ESMO Policy on Media Activities Organised by Third Parties and can request a Third Parties Media badge through registration@esmo.org (Cc media@esmo.org).
Further information
MAP Press Office
press@esmo.org
MAP is a joint initiative of Cancer Research UK (CRUK), Unicancer and the European Society for Medical Oncology (ESMO).
Notes to Editors
Please make sure to use the official name of the meeting in your reports: MAP 2025 and the official congress hashtag #MAP2025. Follow it to stay up to date and use it to take part in the conversation on X, LinkedIn, Bluesky, Instagram, Facebook, YouTube.
About the European Society for Medical Oncology (ESMO)
Representing more than 40,000 oncology professionals from 179 countries and territories, ESMO is a reference for oncology education and information. Driven by a shared determination to secure the best possible outcomes for patients, ESMO is committed to standing by those who care about cancer through addressing the diverse needs of #ONEoncologycommunity, offering #educationforLIFE, and advocating for #accessiblecancerCARE. www.esmo.org
About Cancer Research UK (CRUK)
Cancer Research UK is the world’s leading cancer charity, dedicated to saving and improving lives with our research, influence and information. We carry out world-class research into the prevention, detection and treatment of more than 200 types of cancer through the work of more than 4,000 scientists, doctors and nurses. We make discoveries about cancer that unlock new and better ways to beat it, and we translate these discoveries into new tests, treatments and prevention measures that can save and improve lives in the UK and around the world. Our vision is a world where everybody lives longer, better lives, free from the fear of cancer. Step by step, day by day, our researchers are making this vision a reality thanks to our dedicated community of supporters, partners, donors, fundraisers, volunteers and staff.
About Unicancer
Unicancer is the only French hospital network that is 100% dedicated to the fight against cancer and the only national hospital federation that specializes in cancer. It brings together the 18 French Cancer Control Centers (CLCC) – private non-profit institutions – as well as two affiliated members. A major player in research, Unicancer is the leading academic promoter of clinical trials in oncology in Europe, with more than 120 active studies (national and international), including 50 currently recruiting, promoted by its R&D department. In addition, there are more than 600 trials promoted by the CLCCs. A pioneer in the use of health data, Unicancer has launched since 2014, via its data and partnerships department, five real-life data programs, including ESME (109,000 patients), CANTO (+13,000 patients), and OncoDataHub (ODH) (+60,000 patients). Each year, more than 600,000 patients benefit from the latest scientific, therapeutic, and organizational advances in cancer, driven by an agile model combining excellence, humanism, solidarity, and innovation. www.unicancer.fr
END
Molecular Analysis for Precision Oncology Congress (MAP) 2025: Event Announcement
2025-08-27
ELSE PRESS RELEASES FROM THIS DATE:
Unmasking inflammatory bowel disease in nigeria: a multicenter cross-sectional analysis of clinico-pathological and endoscopic findings
2025-08-27
Background and objectives
Inflammatory bowel disease (IBD) is a chronic condition with significant health implications worldwide. In Nigeria, data on its prevalence and characteristics are limited, highlighting the need for comprehensive studies to better understand its epidemiology and clinical features in the region. This study aimed to assess the clinical presentation, endoscopic findings, and management challenges of IBD among patients undergoing colonoscopy in Nigeria.
Methods
Over five years (2019–2024), ...
Gene therapy leads to improved quality of life in patients with sickle cell disease and beta thalassemia
2025-08-27
(WASHINGTON — August 27, 2025) – Treatment with exagamglogene autotemcel (exa-cel) led to robust and sustained improvements in quality of life for patients with severe sickle cell disease (SCD) or transfusion-dependent beta thalassemia, according to two studies published in Blood Advances.
“This is the first time we’ve been able to measure improvements in quality of life after treatment with gene editing technology,” said Josu de la Fuente, PhD, director of the Paediatric Blood and Marrow Transplantation Programme at Imperial College London Healthcare NHS Trust, professor of practice (Cell & Gene Therapy) at Imperial ...
Seroprevalence 36 months after a single-dose bivalent human papillomavirus vaccination among nine to fifteen-year-old girls in Dhaka, Bangladesh
2025-08-27
Background and objectives
Immunization against human papillomavirus (HPV), particularly with a single-dose vaccine, offers a cost-effective strategy for cervical cancer prevention. This study aimed to evaluate the seroprevalence following a single-dose bivalent HPV vaccine among adolescent girls in Bangladesh and to examine its association with sociodemographic characteristics.
Methods
A cross-sectional study was conducted among 648 adolescent girls (aged nine to fifteen years) in Dhaka, Bangladesh, who received a single dose of the bivalent HPV vaccine in November 2019. Participants were recruited from ten local schools. ...
In a challenging labor market, Black women with disabilities are choosing self-employment
2025-08-27
Media Contact: Karen Addis, APR,karen@addispr.com, 301-787-2394
Alexandria, Va. (Aug. 27, 2025) — While the employment landscape for Black women continues to shift in 2025, Black women with disabilities are actively pursuing self-employment as a viable career option, according to new research published in the Journal of Multicultural Counseling and Development, a publication of the American Counseling Association.
The report, Breaking Barriers: The Economic Realities of Self-Employed Black Women With Disabilities,” is part of a special issue focusing on Black Americans with disabilities. The study captures a ...
SwRI develops an ion-assisted chromatography process to accelerate drug development
2025-08-27
SAN ANTONIO — August 27, 2025 — Southwest Research Institute scientists developed a new purification technique to improve chromatography results without expensive purification materials or equipment. Chromatography is an essential part of drug discovery, development and quality control, allowing scientists to isolate and synthesize active pharmaceutical ingredients (APIs) that meet U.S. Food & Drug Administration purity standards.
“By far the most widely used chromatography purification process relies on silica gel; however, silica fails when purifying extremely ...
Local news services need to adapt or face extinction: report
2025-08-27
Gaps are emerging in the provision of local news across Australia, but embracing community driven content could be key to improving the viability of local news.
A new report from the University of Canberra (UC) and RMIT University – Engaged Journalism in the Heartland: Understanding Regional News Audiences – encompassing multiple studies, proposes recommendations to turn the situation around.
Researchers surveyed audiences, analysed more than 3,000 news stories and interviewed more than 200 people from regional communities across the country.
Report lead author and Director of UC’s News and Media Research Centre, ...
Myocardial infarction may be an infectious disease
2025-08-27
A pioneering study by researchers from Finland and the UK has demonstrated for the first time that myocardial infarction may be an infectious disease. This discovery challenges the conventional understanding of the pathogenesis of myocardial infarction and opens new avenues for treatment, diagnostics, and even vaccine development.
According to the recently published research, an infection may trigger myocardial infarction. Using a range of advanced methodologies, the research found that, in coronary artery disease, atherosclerotic plaques containing cholesterol may harbour a gelatinous, asymptomatic biofilm formed by bacteria over years or even decades. Dormant ...
Access to four-year colleges that effectively serve low-income students is uneven across U.S., new study finds
2025-08-27
Washington, August 26, 2025—A new study finds that four-year colleges and universities that both enroll and graduate low-income students at high rates—termed “Equity Engines” by the author—are unevenly distributed across the United States. Many states have no institutions that meet the criteria. The study was published today in AERA Open, a peer-reviewed journal of the American Educational Research Association.
Conducted by Becca Spindel Bassett, an assistant professor of higher education at the University of Arkansas, the study identifies just 91 Equity Engines out of 1,584 public and private nonprofit ...
American Meteorological Society announces 2026 weather, water, and climate honorees
2025-08-27
The American Meteorological Society announces its 2026 Awards and Honors, recognizing outstanding contributions to the weather, water, and climate community by individuals and organizations. 2026 recipients will be honored at the 106th AMS Annual Meeting in Houston, 25–29 January, 2026.
“Through its awards AMS recognizes some of the many, many exceptional people working across the Weather, Water, and Climate Enterprise to benefit humanity,” says AMS Past President Anjuli Bamzai, chair of the AMS Awards Oversight Committee. “Even as our community is facing a time ...
Transcutaneous vagal nerve stimulation for gastrointestinal disorders
2025-08-27
Imbalanced autonomic function, characterized by reduced vagal activity and sympathetic dominance, is increasingly recognized in various gastrointestinal (GI) disorders. The vagus nerve, a key component of the parasympathetic nervous system, plays a critical role in regulating upper GI motility, inflammation, and pain perception. Transcutaneous vagal nerve stimulation (tVNS) offers a non-invasive method to modulate vagal activity, presenting a promising therapeutic approach for GI conditions. This review synthesizes evidence from clinical trials on the efficacy of tVNS—including transcutaneous ...